High Tower Advisors, LLC Navidea Biopharmaceuticals, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.0 - $1.82 $28,465 - $51,806	-28,465 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$1.55 - $2.15 $20,150 - $27,950	13,000 Added 84.06%	28,465 $51,000
Q1 2021 May 10, 2021	SELL	$1.99 - $2.9 $40,994 - $59,740	-20,600 Reduced 57.12%	15,465 $33,000
Q4 2020 Feb 10, 2021	BUY	$1.88 - $2.84 $8,366 - $12,638	4,450 Added 14.08%	36,065 $79,000
Q3 2020 Nov 13, 2020	BUY	$2.69 - $4.95 $10,961 - $20,171	4,075 Added 14.8%	31,615 $84,000
Q2 2020 Aug 10, 2020	BUY	$0.7 - $4.16 $8,715 - $51,792	12,450 Added 82.5%	27,540 $109,000
Q4 2019 Feb 14, 2020	BUY	$0.65 - $1.26 $1,300 - $2,520	2,000 Added 15.28%	15,090 $18,000
Q3 2019 Nov 12, 2019	SELL	$0.5 - $0.91 $26 - $47	-52 Reduced 0.4%	13,090 $11,000
Q2 2019 Aug 13, 2019	BUY	$0.62 - $3.6 $8,148 - $47,311	13,142 New	13,142 $5,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.